Antibiotics for the treatment of dysentery in children

被引:49
|
作者
Traa, Beatrix S. [1 ]
Walker, Christa L. Fischer [2 ]
Munos, Melinda [2 ]
Black, Robert E. [2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
基金
比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;
关键词
Ciprofloxacin; ceftriaxone; pivmecillinam; diarrhoea; dysentery; morbidity; mortality; treatment; COMPARATIVE EFFICACY; SHIGELLA-DYSENTERIAE; BACILLARY DYSENTERY; CEFTRIAXONE; PIVMECILLINAM; AMPICILLIN; PATHOGENS;
D O I
10.1093/ije/dyq024
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years. Methods We reviewed all literature reporting the effect of ciprofloxacin, ceftriaxone and pivmecillinam for the treatment of dysentery in children in the developing countries. We used a standardized abstraction and grading format and performed meta-analyses to determine the effect of treatment with these antibiotics on rates of treatment failure, bacteriological failure and bacteriological relapse. The CHERG Standard Rules were applied to determine the final effect of treatment with these antibiotics on diarrhoea mortality. Results Eight papers were selected for abstraction. Treatment with ciprofloxacin, ceftriaxone or pivmecillinam resulted in a cure rate of >99% while assessing clinical failure, bacteriological failure and bacteriological relapse. Conclusions The antibiotics recommended by the WHO-ciprofloxacin, ceftriaxone and pivmecillinam-are effective in reducing the clinical and bacteriological signs and symptoms of dysentery and thus can be expected to decrease diarrhoea mortality attributable to dysentery.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 50 条